NCT02062801View on ClinicalTrials.gov

Prophylactic Ephedrine and Combined Spinal Epidurals for Labor

PHASE4CompletedINTERVENTIONAL

Enrollment

710

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

October 31, 2013

Conditions

Labor Pain

Interventions

DRUG

Ephedrine

Patients received additional doses of ephedrine 10mg IV to a maximum of 30mg if BP remained low (\<90mmHg systolic) and/was associated with persistent fetal bradycardia or maternal symptoms of dizziness and nausea

DRUG

Placebo

Patients received normal saline (placebo) administered immediately after combined spinal epidural (CSE) placement

Trial Locations (1)

92123

Sharp Mary Birch Hospital for Women and Newborns, San Diego

All Listed Sponsors

lead

Sharp HealthCare

OTHER

NCT02062801 - Prophylactic Ephedrine and Combined Spinal Epidurals for Labor | Biotech Hunter | Biotech Hunter